Form 4 for ZBH Zimmer Biomet
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0001062993-25-002916 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-18 | ZBH | Winkler Lori | SVP, CHRO | M - OptEx | $0.00 | +7,208 | 10.6K | +214% | $0 |
| D | 2025-02-19 | 2025-02-18 | ZBH | Winkler Lori | SVP, CHRO | F - Tax | $101.00 | -1,802 | 8,769 | -17% | -$182.0K |
| D | 2025-02-19 | 2025-02-18 | ZBH | Winkler Lori | SVP, CHRO | M - OptEx | $0.00 | -7,208 | 0 | -100% | $0 |
| D | 2025-02-19 | 2025-02-14 | ZBH | Winkler Lori | SVP, CHRO | A - Grant | $0.00 | +7,208 | 7,208 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | M | A | 7,208 | $0.00 | 10,571 | D | — | — | (F1) Includes 27 shares acquired pursuant to dividend reinvestment through February 18, 2025. |
| 2 | Common | Common Stock | 2025-02-18 | F | D | 1,802 | $101.00 | 8,769 | D | — | — | (F2) Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). |
| 3 | Derivative | Restricted Stock Units | 2025-02-18 | M | D | 7,208 | $0.00 | 0 | D | — · 2025-02-18 to 2025-02-18 | 7,208 Common Stock | (F3) Each RSU represents a contingent right to receive one share of Company common stock. |
| 4 | Derivative | Restricted Stock Units | 2025-02-14 | A | A | 7,208 | $0.00 | 7,208 | D | — · 2025-02-18 to 2025-02-18 | 7,208 Common Stock | (F4) On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 7,208 RSUs, which vested on February 18, 2025. (F3) Each RSU represents a contingent right to receive one share of Company common stock. |